Back to search
Still Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Still Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Still Disease trials you may qualify forPrimary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 1-17 years with Systemic Juvenile Idiopathic Arthritis (sJIA) in…
The study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 in pediatric and adult participants with Still's di…
This is an observational study in which data are collected and studied from Parkinson's disease patients who have movement symptoms despite taking standard Park…
Background: Inflammatory conditions can cause symptoms like fevers, arthritis, and rash. Systemic juvenile idiopathic arthritis (sJIA) is one of these conditio…
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
Background: Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH are prone to fevers and illnesses, which…
This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Fa…
The goal of this clinical trial is to determine whether performing total knee replacement surgery (total knee arthroplasty, TKA) without a tourniquet is clinica…
This study was designed to evaluate the efficacy and safety of canakinumab administered subcutaneously every 4 weeks for at least 48 weeks in Japanese patients…